Possible role of tau protein kinases in pathogenesis of Alzheimer's disease
- PMID: 9562476
- DOI: 10.1016/s0197-4580(98)00025-6
Possible role of tau protein kinases in pathogenesis of Alzheimer's disease
Abstract
Tau protein kinases (TPK) I and II were isolated as candidate enzymes responsible for the hyperphosphorylation observed in PHF-tau. Four phosphorylation sites of tau were identified for each kinase, accounting for most, but not all, of the major phosphorylation sites of PHF-tau. Immunostaining with anti-TPKI antibody indicated that this kinase is up-regulated in AD brain. Such up-regulation of TPKI and phosphorylatioin of tau were reproduced by treating cultured hippocampal cells with amyloid beta (Abeta) protein. In addition, we found that TPKI can phosphorylate and inactivate pyruvate dehydrogenase (PDH), which is expected to result in depletion of acetyl-CoA, a key substrate of acetyl choline synthesis. Indeed, when septum cells were treated with Abeta, the level of acetyl choline decreased dramatically.
Similar articles
-
Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.J Biochem. 1997 Feb;121(2):179-88. J Biochem. 1997. PMID: 9089387 Review.
-
Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.Curr Biol. 1994 Dec 1;4(12):1077-86. doi: 10.1016/s0960-9822(00)00246-3. Curr Biol. 1994. PMID: 7704571
-
Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain.Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2719-23. doi: 10.1073/pnas.93.7.2719. Proc Natl Acad Sci U S A. 1996. PMID: 8610107 Free PMC article.
-
Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse.J Biol Chem. 2001 Sep 7;276(36):34298-306. doi: 10.1074/jbc.M102780200. Epub 2001 Jul 5. J Biol Chem. 2001. PMID: 11441005
-
[Involvement of tau protein kinase in amyloid-beta-induced neurodegeneration].Rinsho Byori. 1998 Oct;46(10):1003-7. Rinsho Byori. 1998. PMID: 9816911 Review. Japanese.
Cited by
-
Tau protein modifications and interactions: their role in function and dysfunction.Int J Mol Sci. 2014 Mar 18;15(3):4671-713. doi: 10.3390/ijms15034671. Int J Mol Sci. 2014. PMID: 24646911 Free PMC article. Review.
-
No difference in kinetics of tau or histone phosphorylation by CDK5/p25 versus CDK5/p35 in vitro.Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):2884-9. doi: 10.1073/pnas.0912718107. Epub 2010 Feb 1. Proc Natl Acad Sci U S A. 2010. PMID: 20133653 Free PMC article.
-
The Toll-->NFkappaB signaling pathway mediates the neuropathological effects of the human Alzheimer's Abeta42 polypeptide in Drosophila.PLoS One. 2008;3(12):e3966. doi: 10.1371/journal.pone.0003966. Epub 2008 Dec 17. PLoS One. 2008. PMID: 19088848 Free PMC article.
-
Does overexpression of betaAPP in aging muscle have a pathogenic role and a relevance to Alzheimer's disease? Clues from inclusion body myositis, cultured human muscle, and transgenic mice.Am J Pathol. 1998 Dec;153(6):1673-7. doi: 10.1016/s0002-9440(10)65680-5. Am J Pathol. 1998. PMID: 9846956 Free PMC article. No abstract available.
-
Bioenergetics breakdown in Alzheimer's disease: targets for new therapies.Int J Physiol Pathophysiol Pharmacol. 2011;3(2):133-9. Epub 2010 Jun 12. Int J Physiol Pathophysiol Pharmacol. 2011. PMID: 21760971 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical